Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (3203)	12/7/1997 11:49:00 PM
From: JOHN W.	Read Replies (1) \| Respond to of 6136

This was the quote I have been refering to as dishonest: "But an anlyst said that could change next year, when three companies -- Abbott Laboratories Inc (NYSE:ABT - news), Glaxo Wellcome Plc (GLXO.L), and Vertex Pharmaceuticals Inc (Nasdaq:VRTX - news) -- are expected to introduce new protease inhibitors with fewer side effects." First of all, VRTX and GLXO.L drug is the same one, (probably the most shameless lie) Secondly, Abotts is not new, just like Fortovase is not new, just saq. (I also find it interesting that some articles talk about 5 PIs on the mkt now, they count saq and fortovase as different. VRTX will be very lucky to get VX-478 on the mkt in 98. Thirdly what is the basis for fewer side effects. What public information/data confirms the superior side-effect profile of Vrtx Pi over Viracept? I say B.S., just making stuff up again. This statement clearly indicate 3 companies will introduce 3 new PIs next year. the informed investor here knowsn this is false, yet it is a lie that will effect the short term price. So why did crossen do this??? He may have been misquoted?He may be trying to manipulate?? I don't know, but I am here saying this is absolutely false. Analyst; If three new protease inhibitors come on the mkt next year, I will give you all my assets (whats left) and kill myself. Want to make the same bet? He deliberately is trying to mis-lead against AGPH.